MedPath
NMPA Approval

Ursodeoxycholic Acid Oral Suspension

国药准字H20253746

April 1, 2025

Drug Information

熊去氧胆酸口服混悬液

口服混悬剂

250ml:12.5g

化学药品

April 1, 2025

Company Information

Applicant Company

中国(四川)自由贸易试验区成都高新区和民街366号3号楼4层402号

Manufacturing Company

江苏丹阳经济开发区顺康路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

熊去氧胆酸口服混悬液 - NMPA 批准文号 | MedPath